Patients are at the center of all our designs. We have been around for more than 60 years, and we know by experience that a "one size fits all" approach is the wrong approach when it comes to design. We need to understand your particular patient population, how these patients deal with their illness, and how their lives and therapy outcomes can be improved so that we can succeed at creating a differentiated device.
- Usefulness: meets a specific need within the targeted therapy
- Intuitiveness: self-explanatory and easy to use
- Desirability: appeals to the patient administering the medication
With these principles in mind, we apply three methods:
In design research, we conduct interviews, contextual observations, participatory workshops, and many other activities to establish a clear, data-driven foundation for building our design.
Industrial design covers the tangible translation of design research inputs into industrial design outputs. We build 3D models, physical modeling, and prototyping, so we meet the requirements defined by the design research.
Human Factors Engineering
Good HFE improves product safety and efficacy. HFE primarily covers product safety and efficacy. We conduct product-handling studies, use error analysis, usability testing, and usability validation to meet regulatory requirements.
Rather than deciding upfront, we pick technologies based on the results of thorough analysis.
Being a part of Molex, we have global access to the most innovative and customizable electronics imaginable. We use this access as a capability throughout design and development to improve the product’s user experience and enhance the effectiveness of the product.
As the global leader in connected health, we think in connected ecosystems and make your product a part of a more effective, connected health system — one that simultaneously benefits patients, healthcare providers, and payers. We are among few vendors globally capable of developing regulated embedded system software and digital interfaces (apps). We have approved software in the market as proof of our strength and experience in this area.
Great products and proper documentation go hand in hand, and you need extensive documentation before you can get the regulatory approval to go to market.
When designing, we assess all risks through various failure mode that examines risks from Use, System, Design, and Process perspectives. We have a compliant and robust quality management system, which allows us to speed up the documentation and quality assurance processes at this stage. As the project moves forward we perform the required versioning control of all documents, supporting a secure regulatory approval of your product.
To hit stringent cost targets we design for manufacturability and assembly upfront. As part of the design and development phase, we do concurrent engineering to ensure our ability to manufacture and assemble the design at later stages and ensure we meet cost targets and deliver on time. DfM and DfA are integrated aspects of our designs, allowing for a smoother execution of the project.
When partnering with customers, we truly believe it benefits both parties to engage as early as possible. We have seen many endeavors go wrong when multiple suppliers are brought together. Their different expectations and standards often delay deliverables, extending the development and manufacturing time and muddying accountability. When we are with you from the beginning, we can create a better design, develop a more desirable device, and plan our manufacturing strategy from the very beginning. All these elements will help you get a differentiated device delivered on time at a lower cost.
View Whitepapers, Blogs, and Other Resources
The Global Innovation and Development team of Phillips-Medisize, a Molex company, considers the approach to developing a novel drug delivery device for age-related macular degeneration.